Chemomab Therapeutics Ltd. — Director's Dealing 2021

Nov 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-10-25

Reporting Person: Pfost Dale R (Director, Chief Executive Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase American Depositary Shares	$10.05	2031-10-25	American Depositary Shares (459353)		Direct

Footnotes

F1: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

F2: The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.